InspireMD (NSPR)
(Delayed Data from NSDQ)
$2.91 USD
-0.05 (-1.69%)
Updated Aug 16, 2024 04:00 PM ET
4-Sell of 5 4
F Value C Growth A Momentum D VGM
Price, Consensus and EPS Surprise
NSPR 2.91 -0.05(-1.69%)
Will NSPR be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NSPR based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for NSPR
InspireMD, Inc. (NSPR) Reports Q2 Loss, Misses Revenue Estimates
Shockwave Medical (SWAV) Q1 Earnings and Revenues Top Estimates
NSPR: What are Zacks experts saying now?
Zacks Private Portfolio Services
InspireMD's (NSPR) CE Mark Recertification to Boost CGuard EPS
Down -24.61% in 4 Weeks, Here's Why InspireMD, Inc. (NSPR) Looks Ripe for a Turnaround
Sight Sciences, Inc. (SGHT) Reports Q2 Loss, Tops Revenue Estimates
Other News for NSPR
InspireMD, Inc. (NSPR) Q2 2024 Earnings Call Transcript
NSPR Stock Earnings: InspireMD Misses EPS, Misses Revenue for Q2 2024
InspireMD Reports Second Quarter 2024 Financial Results and Provides Business Update
InspireMD GAAP EPS of -$0.22, revenue of $1.74M
InspireMD reports Q2 EPS (22c) vs (24c) last year